Burundi has successfully scaled up mass drug administration (MDA) against onchocerciasis, achieving therapeutic coverage of more than 80% since 2010. In 2021, an independent expert committee for the elimination of onchocerciasis has been created.
Join the webinar on 3 September and learn about ongoing elimination efforts while facing logistical challenges, how onchocerciasis is integrated into other health campaigns, and how the country is preparing for the results of previous evaluations (onchocerciasis elimination mapping) and the pre-Stop MDA survey.
--------------------------------------
Agenda
| Welcome and introductions Dr Didier Bakajika, WHO/AFRO/ESPEN, Technical Officer for onchocerciasis and lymphatic filariasis |
| Country progress towards NTD 2030 Road Map targets for onchocerciasis in Togo: Progress, challenges and critical actions Dr Victor Bucumi, Director of the NTD program, Minister of Public Health and the Fight against AIDS, Burundi |
| Partners' perspectives: the role and contribution of partners in the efforts to eliminate onchocerciasis in Burundi Johan Willems, Global NTD Program Manager, CBM END Fund (TBC) |
| Cross-border collaboration with neighboring countries Dr Naomi Awaca Uvon, National Coordinator for Onchocerciasis, Ministry of Health, Democratic Republic of Congo Dr Ladislas Nshimiyimana, NTD Research Senior Officer, Ministry of Health/Rwanda Biomedical Centre Dr Clara Jones, NTD Program Director, Ministry of Health, Tanzania |
Languages: English and French